Race for better fungal infection treatment halted early
Disease control
Terminated
This study aimed to compare two different oral antifungal treatments for patients with serious Candida bloodstream or tissue infections. After receiving initial intravenous treatment, participants were randomly assigned to receive either oral ibrexafungerp or oral fluconazole. Th…
Phase: PHASE3 • Sponsor: Scynexis, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC